Berbamine hydrochloride: Precision NF-κB Inhibitor and Anticancer Compound for Research

Executive Summary: Berbamine hydrochloride (SKU N2471) is an isoquinoline alkaloid derivative isolated from Berberidaceae plants, with a primary function as an NF-κB and STAT3 pathway inhibitor (APExBIO, product page). It demonstrates potent anticancer effects in KU812 leukemia cells (IC50: 5.83 μg/ml, 24h) and HepG2 hepatocellular carcinoma cells (IC50: 34.5 µM), underpinned by apoptosis induction and cytotoxicity (Wang et al., DOI:10.1186/s13045-024-01599-6). The compound is soluble in DMSO, water, and ethanol, facilitating broad experimental integration. Its efficacy aligns with recent advances in ferroptosis and tumorigenesis research. APExBIO supplies this compound at ≥97.4% purity for research use only.

Biological Rationale

Berbamine hydrochloride is a small molecule derived from plants of the Berberidaceae family and is classified as an isoquinoline alkaloid. It has a molecular weight of 681.65 and chemical formula C₃₇H₄₂Cl₂N₂O₆. Its complex structure enables targeted modulation of cell signaling pathways critical in tumorigenesis, such as NF-κB and STAT3. The compound’s anticancer activity is particularly relevant for cancer cell lines exhibiting aberrant proliferation and resistance to apoptosis. In the context of hepatocellular carcinoma (HCC), the METTL16-SENP3-LTF axis has emerged as a pivotal regulator of ferroptosis resistance and tumor progression, highlighting the need for efficacious pathway inhibitors in experimental oncology (Wang et al. 2024).

Mechanism of Action of Berbamine hydrochloride

Berbamine hydrochloride acts as a multi-pathway modulator with primary inhibition of NF-κB and STAT3 signaling (mechanistic review). By blocking NF-κB activity, the compound reduces transcription of genes involved in cell survival, inflammation, and immune evasion. It also disrupts intracellular calcium homeostasis, which further sensitizes cancer cells to apoptosis. In HepG2 HCC cells, Berbamine hydrochloride shows potential to counteract ferroptosis resistance maintained by the METTL16-SENP3-LTF axis, distinguishing it from conventional cytotoxic agents (advanced strategies article). This dual action on survival and death pathways positions Berbamine hydrochloride as an advanced tool for dissecting cell fate in cancer models.

Evidence & Benchmarks

• Berbamine hydrochloride inhibits proliferation of KU812 leukemia cells with an IC50 of 5.83 μg/ml after 24 hours (Wang et al. 2024, DOI:10.1186/s13045-024-01599-6).
• In HepG2 hepatocellular carcinoma cells, Berbamine hydrochloride achieves an IC50 of 34.5 μM, indicating substantial cytotoxicity (Wang et al. 2024, DOI:10.1186/s13045-024-01599-6).
• The compound disrupts STAT3 activation, a pathway implicated in cancer cell survival and immune modulation (Berbamine NF-κB Inhibitor Mechanisms).
• Berbamine hydrochloride modulates intracellular calcium levels, sensitizing tumor cells to apoptosis (Advanced Strategies Article).
• Solubility benchmarks: ≥68 mg/mL in DMSO, ≥10.68 mg/mL in water, and ≥4.57 mg/mL in ethanol (APExBIO, product page).
• Supplied at ≥97.4% purity, ensuring high reproducibility in sensitive cytotoxicity and signal transduction assays (Precision Cytotoxicity article).

Applications, Limits & Misconceptions

Berbamine hydrochloride is widely employed in cancer biology, immunology, and drug screening platforms. It is used to interrogate the roles of NF-κB and STAT3 in tumorigenesis, to induce apoptosis in resistant cancer cell lines, and to model ferroptosis resistance in HCC research. The compound is particularly valued for its robust solubility profile and stability at -20°C, making it suitable for workflows involving repeated freeze-thaw cycles and diverse assay formats. While its efficacy in KU812 and HepG2 models is well established, users should note that results may vary across cell types and experimental conditions. APExBIO provides detailed guidance to optimize use and ensure data fidelity.

Common Pitfalls or Misconceptions

• Not a diagnostic or therapeutic agent: Berbamine hydrochloride is for research use only; it is not approved for clinical or diagnostic applications (APExBIO, product page).
• Long-term solution instability: Solutions are not recommended for extended storage; use prepared solutions promptly for reliable results.
• Cell line specificity: Potency benchmarks are established for KU812 and HepG2; extrapolation to other lines or in vivo settings must be validated independently.
• Solubility miscalculations: Solubility must be confirmed in the intended solvent system; ethanol and DMSO have different maximum solubility limits.
• NF-κB-independent effects: Not all observed bioactivities may be attributable solely to NF-κB inhibition; off-target effects should be considered in experimental design (Next Frontier in Cancer Research article).

Workflow Integration & Parameters

Berbamine hydrochloride (SKU N2471) is provided as a solid, high-purity compound. Recommended storage is at -20°C; shipping is performed on blue ice for stability. For in vitro work, dissolve in DMSO (≥68 mg/mL), water (≥10.68 mg/mL), or ethanol (≥4.57 mg/mL) directly prior to use. Avoid prolonged storage of solutions. For cytotoxicity and apoptosis assays, reference IC50 concentrations for KU812 (5.83 μg/ml, 24h) and HepG2 (34.5 μM) as starting points. Protocols should incorporate appropriate negative and positive controls, and results must be interpreted within the context of each specific cell type and experimental paradigm. For guidance on assay design and troubleshooting, see the scenario-driven workflows in the Precision Cytotoxicity article, which offers detailed troubleshooting and reproducibility insights that go beyond this overview.

Conclusion & Outlook

Berbamine hydrochloride is a benchmark NF-κB inhibitor and anticancer compound, integrating robust solubility, reproducibility, and mechanistic specificity for research in oncology and immunology. Its dual action on NF-κB/STAT3 and calcium signaling, coupled with efficacy in ferroptosis resistance studies, marks it as a critical asset for dissecting tumor cell biology. Ongoing research, including mechanistic dissection of the METTL16-SENP3-LTF axis, will expand its applications in advanced cancer models. For further details, refer to the Berbamine hydrochloride product page at APExBIO. This article extends prior discussions by integrating the latest evidence on ferroptosis resistance and workflow optimization, as compared to the Next Frontier in Cancer Research article, which focuses on broader translational outlooks.